OTC · KAST
Kasten, Inc.
Financial Services · Shell Companies
$4.00
Up+$3.97 (+13233.33%)
Updated Sep 10, 2026, 10:54 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 164.56M
- P/E ratio
- 1,411.6
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 957.9K
- Avg. volume
- 126
Price performance
KAST price history
1M range · 0 trading sessions · Daily adjusted prices
KAST does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest KAST news
The latest Smart Investors Daily articles mentioning KAST.
Stock researchCompany · Overview
KAST research
Overview
Company profile and research snapshot.
Company profile
Kasten, Inc., doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings. It principally focuses on delivering solutions to those people who are affected by antimicrobial resistance and who need pharmaceutical products at affordable prices. The company was incorporated in 1986 and is based in Sioux Falls, South Dakota.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
